stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) P/B ratio
As of 6 November 2026, Fortrea Holdings Inc. (FTRE) trades at a P/B ratio of 3.9×. Over the past ten years it has ranged from 0.4× (May 2025) to 4.6× (October 2026); the current reading is higher than 99% of that period. That is above the Biotechnology industry median of 2.1× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.8× | 127.86% |
| FY2024 | 1.2× | (31.37%) |
| FY2023 | 1.8× | 127.47% |
| FY2022 | 0.8× | 0.00% |
| FY2021 | 0.8× | 0.00% |
| FY2020 | 0.8× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 3.6× | 13.87% |
| Jun 2026 | 3.1× | 87.68% |
| Mar 2026 | 1.7× | (39.95%) |
| Dec 2025 | 2.8× | 111.16% |
| 13 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BHVN Biohaven Ltd. compare | n/m |
| SRPT Sarepta Therapeutics, Inc. compare | 1.2× |
| HRMY Harmony Biosciences Holdings, Inc. compare | 1.8× |
| VIR Vir Biotechnology, Inc. compare | 2.3× |
| FTRE Fortrea Holdings Inc. | 3.9× |
| IMNM Immunome, Inc. compare | 4.0× |
| REPL Replimune Group, Inc. compare | 11.2× |
| TRAX First Tracks Biotherapeutics, Inc. compare | 11.3× |
| ZYME Zymeworks Inc. compare | 26.8× |
| Biotechnology industry median | 2.1× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))